Solesence, Inc. (SLSN)

Nasdaq: SLSN · Perfumes, Cosmetics & Other Toilet Preparations · Romeoville, IL · filing with the SEC since 1997

Full chart Alerts Compare

Grade4.6

◀ Past 2.9● Present 4.9▶ Future 5.9

2 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The grade of Solesence, Inc.

Nine metrics read from its own filings, by tense

Headline grade

4.6/10

◀ Past2.930% of the headline

● Present4.940% of the headline

▶ Future5.930% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 7 read as filed from the record and 2 are SI estimates, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

2.9/1030% of the headline grade · 2 of 3 filed, 1 estimated

Surviving crises

as filed

0.6/10

Has it survived what it has been through?

7 warning events since 2017; the latest 2026-10-02.

weight 33% of this tense · 6th percentile among 18 sector filers · read for itself

From the record

Solesence, Inc.'s filings since 2017 show 7 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, the latest 2026-10-02); a warning not to rely on past financial statements (8-K item 4.02, 2 times, the latest 2026-08-21); a late-report notice (Form NT 10-K or NT 10-Q, 4 times, the latest 2026-08-14) (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed

5.0/10

What has it actually done, year after year?

+23.5% a year over 8 filed years; profitable in 4 of 8.

weight 45% of this tense · 50th percentile among 16 sector filers · read for its customers

From the record

Solesence, Inc.'s 8 filed years say what it did: revenue went from $14 million in fiscal 2018 to $62 million in fiscal 2025, up 23.5% a year; it rose in 5 of 7 years; the deepest fall was 12% from fiscal 2018 to fiscal 2019; net income was positive in 4 of 8 of those years (its annual reports).

What it rests on

revenue growth over the filed span23.5%top 47% of its family
the share of years revenue rosetop 47% of its family
the share of filed years with a profitbottom 41% of its family
the deepest fall from a revenue peak11.9%top 47% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

SI estimate

2.3/10

How has it treated the people who own it?

SI estimate 2.3/10, confidence 35 of 100 (one part).

weight 22% of this tense · 23rd percentile among 16 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Read from one part only, the share count over the years, which ranks in the bottom 23% of 16 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
What the record cannot read: Fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income.
How it was reasoned: one part: the share count over the years, the one part on file, ranked among 16 in its family.
Confidence: 35 of 100
What would change it: A filing that carries the missing parts replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Solesence, Inc.'s shareholder treatment is put at 2.3 of 10 with a confidence of 35 of 100, because read from one part only, the share count over the years, which ranks in the bottom 23% of 16 in its family; fewer than two of the parts can be read: the share count over the years, and the cash returned against a positive operating cash flow or net income. A filing that carries the missing parts replaces this estimate with the filed reading.

● Present

What are they doing right now?

4.9/1040% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed

4.0/10

Is it financially healthy right now?

ROE 20%: 20¢ of profit per shareholder dollar. Leverage 70%: owes 70¢ per asset dollar.

weight 45% of this tense · 40th percentile among 17 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Solesence, Inc. earned about 20 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 37 cents per dollar of everything the company owns. Leverage: it owed about 70 cents per dollar of assets, and net share issuance: its share count grew 11.6% over the year (the filed statements).

What it rests on

what it owes per dollar of assetsbottom 21% of its family
return on equitytop 21% of its family
gross profit against assetsbottom 44% of its family
the share count against the year beforebottom 17% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed

5.7/10

How strong is its position in its industry?

top 43% of 17 in its family; net margin 4.5%.

weight 33% of this tense · 57th percentile among 17 sector filers · read for its customers

From the record

Solesence, Inc.'s standing among 17 graded names in its industry family: revenue of $62 million in fiscal 2025 ranks in the bottom 37% by size; a net margin of 4.5% ranks in the top 44%; revenue growth of 18.5% a year over the last 3 filed years ranks in the top 22% (its annual reports).

What it rests on

revenue against the family$62.1Mbottom 37% of its family
net margin4.5%top 44% of its family
three-year revenue growth18.5%top 22% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate

5.6/10

What are the people in charge doing?

SI estimate 5.6/10, confidence 20 of 100 (family median).

weight 22% of this tense · 50th percentile among 11 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: Fewer than two of the three parts can be read: officer and director changes against the people in charge, the years the people in charge have been filing, the chief executive's years under the title, so the desk assumes the typical reading of its industry family, the median of 11 members with one.
What the record cannot read: Fewer than two of the three parts can be read: officer and director changes against the people in charge, the years the people in charge have been filing, the chief executive's years under the title.
How it was reasoned: family median, 11 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Solesence, Inc.'s leadership is put at 5.6 of 10 with a confidence of 20 of 100, because fewer than two of the three parts can be read: officer and director changes against the people in charge, the years the people in charge have been filing, the chief executive's years under the title, so the desk assumes the typical reading of its industry family, the median of 11 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

5.9/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed

4.2/10

How much room does it have to grow?

bottom 42% of 17 in its family for room to expand.

weight 45% of this tense · 42nd percentile among 17 sector filers · read for itself

From the record

Solesence, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $1 million against no long-term debt tagged leaves 2.8% of its assets as net cash, top 43% of its family; cash from operations less capital spending is -13.8% of revenue (bottom 15%); a gross margin of 27.5% (bottom 3%); research spending of 6.6% of revenue (top 5%) (its annual report).

What it rests on

cash less debt against assets2.8%top 43% of its family
cash from operations less capital spending against revenue-13.8%bottom 15% of its family
gross margin27.5%bottom 3% of its family
research spending against revenue6.6%top 5% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed

6.8/10

What could actually drive growth from here?

top 32% of 16 in its family for growth drivers.

weight 33% of this tense · 68th percentile among 16 sector filers · read for its customers

From the record

Solesence, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 18.5% a year over the last three filed years against 23.5% over all 8, slowing (bottom 28% of its family); the newest year grew 18.6% (top 28%); research spending grew 10.4% a year (top 14%); capital spending grew 34.5% a year (top 16%) (its annual reports). Solesence, Inc. reported 4 product lines in fiscal 2025: Consumer Products at $55 million (88%), Personal Care Ingredients at $6 million (10%), Advanced Materials at $857 thousand (1%), and 1 more; 1 of 4 grew against the year before (its annual report).

What it rests on

three-year growth against the whole span-5.0 points a yearbottom 28% of its family
the newest year's revenue growth18.6%top 28% of its family
three-year growth of research spending10.4%top 14% of its family
three-year growth of capital spending34.5%top 16% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed

8.0/10

Did its newest year beat what its own record pointed to?

top 20% of 16 in its family for expectations against reality.

weight 22% of this tense · 80th percentile among 16 sector filers · read for its shareholders

From the record

Solesence, Inc.'s newest year against its own record: revenue of $62 million in fiscal 2025 came in 0.1% above the $62 million its prior three years' pace pointed to (top 34% of its family); net income of $3 million against a prior three-year average of $2 million (top 3%); a net margin of 4.5% against -6.1% before (top 22%) (its annual reports).

What it rests on

revenue against the prior three years' pace0.1%top 34% of its family
net income against the prior three years' average+230%top 3% of its family
net margin against its prior average+10.6 pointstop 22% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton SLSN · research, not advice